John Nicholson
2013
In 2013, John Nicholson earned a total compensation of $1.7M as Senior Vice President and Chief Financial Officer at Nektar Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $276,000 |
|---|---|
| Option Awards | $849,834 |
| Salary | $524,264 |
| Other | $12,112 |
| Total | $1,662,210 |
Nicholson received $849.8K in option awards, accounting for 51% of the total pay in 2013.
Nicholson also received $276K in non-equity incentive plan, $524.3K in salary and $12.1K in other compensation.
Rankings
In 2013, John Nicholson's compensation ranked 4,552nd out of 12,286 executives tracked by ExecPay. In other words, Nicholson earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,552 out of 12,286 | 63rd |
Division Manufacturing | 1,557 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 449 out of 1,466 | 69th |
Industry group Drugs | 312 out of 1,160 | 73rd |
Industry Pharmaceutical Preparations | 250 out of 890 | 72nd |
Source: SEC filing on April 29, 2016.
Nicholson's colleagues
We found four more compensation records of executives who worked with John Nicholson at Nektar Therapeutics in 2013.